Posts Tagged syringe-needles

QD Syringe Systems ::: Quick Draw Syringe Systems

Saturday, October 8th, 2011 | Permalink

QD Syringe Systems (QDSS) was founded by it’s visionary CEO, Christopher Green. The goal of QDSS is to bring to market the most basic ergonomic revolutionary disposable syringe the world has ever seen. From its early beginnings, special attention has always been on maximum safety, functionality, ergonomics and cost reduction

Link:
QD Syringe Systems ::: Quick Draw Syringe Systems

Lets Get ALL Safety Syringes To The Market!

Wednesday, September 28th, 2011 | Permalink

Please view the video below! Only the BEST Safety Syringes should be in the hands of medical personnel. Nothing should stand in the way of saving lives. There should be no type of financial gain that overrides safety.  There should be no ” Join the club – Kickback ” politics to get your superior product to the market.

View article:
Lets Get ALL Safety Syringes To The Market!

Syringe, Syringes, Safety Syringes, QD Syringe Systems

Wednesday, September 28th, 2011 | Permalink

QD Syringe Systems ::: Syringes, Safety Syringes, Safe Syringes, Syringe, QD2 Syringe, The Syringe Revolution. Its time has come.

Original post:
Syringe, Syringes, Safety Syringes, QD Syringe Systems

Safety Syringes

Friday, September 16th, 2011 | Permalink

Safety Syringes, Safety Syringe, Disposable Syringes, QD Syringe, QD2 Syringe, AnestaWeb, Inc.

See more here:
Safety Syringes

FDA Clears All-in-One Reconstitution/Administration Syringe for Xyntha

Tuesday, November 2nd, 2010 | Permalink

FDA Clears All-in-One Reconstitution/Administration Syringe for Xyntha Information from Industry Four experts review metastatic GIST case Connect with the GIST Exchange to view a new program on diagnosising and treating metastatic progressive gastrointestinal stromal tumors (GIST) in a 55-year-old male. Review case study August 10, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a device (Prefilled Dual-Chamber Syringe; Pfizer, Inc) used to reconstitute and administer antihemophilic factor (recombinant) plasma/albumin-free intravenous infusion (Xyntha; Pfizer) in patients with hemophilia A. The all-in-one syringe is the first to supply freeze-dried albumin-free recombinant factor VIII and also the diluent (0.9% sodium chloride), thereby eliminating the reconstitution transfer step and improving patient convenience.

Read More:
FDA Clears All-in-One Reconstitution/Administration Syringe for Xyntha